Neoadjuvant pembrolizumab in advanced melanoma

Neoadjuvant pembrolizumab in advanced melanoma

Bibliographic Details
Main Authors:	Praful Pandey, Ajay Gogia
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Cancer Research, Statistics, and Treatment
Online Access:	http://www.crstonline.com/article.asp?issn=2590-3233;year=2023;volume=6;issue=2;spage=360;epage=360;aulast=Pandey

Similar Items

Pembrolizumab as adjuvant therapy in melanoma
by: Shuvadeep Ganguly, et al.
Published: (2022-01-01)

Spotlight on pembrolizumab in the treatment of advanced melanoma
by: Rajakulendran T, et al.
Published: (2015-06-01)

Rucaparib in metastatic prostate cancer
by: Praful Pandey, et al.
Published: (2023-01-01)

Efficacy of neoadjuvant pembrolizumab in a primary cutaneous stage II non-operated melanoma
by: M. Amiot, et al.
Published: (2024-12-01)

Challenging the standard of care in advanced melanoma: focus on pembrolizumab
by: Abdul-Karim RM, et al.
Published: (2017-09-01)

Neoadjuvant followed by adjuvant pembrolizumab in melanoma: time biases in the data analysis of the SWOG S1801 trial.
by: Timothée Olivier, et al.
Published: (2024-07-01)

Successful Neoadjuvant Therapy with Pembrolizumab Monotherapy for Advanced Ascending Colon Cancer
by: Chien-Tzu Huang*, et al.
Published: (2023-07-01)

Breast-conserving surgery without irradiation in early breast cancer
by: Supriya Mallick, et al.
Published: (2023-01-01)

Tumor-infiltrating lymphocyte therapy versus ipilimumab in advanced melanoma
by: Shuvadeep Ganguly, et al.
Published: (2023-01-01)

Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis
by: Zhang Qi, et al.
Published: (2020-06-01)

The emergence of neoadjuvant therapy in advanced melanoma
by: James Sun, et al.
Published: (2019-11-01)

PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2017-06-01)

Cost-effectiveness analysis of pembrolizumab versus targeted therapies in advanced melanoma
by: E. G. Kosolapov, et al.
Published: (2018-05-01)

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma
by: Ann W. Silk, et al.
Published: (2023-02-01)

Neoadjuvant cemiplimab for stages II to IV cutaneous squamous cell carcinoma
by: Sushant Chib, et al.
Published: (2022-01-01)

Neoadjuvant chemotherapy in locally advanced invasive lobular carcinoma: A limited institutional experience
by: Ajay Gogia, et al.
Published: (2018-01-01)

Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study
by: Lu Si, et al.
Published: (2022-10-01)

Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma
by: Ester Simeone, et al.
Published: (2017-03-01)

Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
by: Frederik Uttenthal Larsen, MD, et al.
Published: (2019-06-01)

Pembrolizumab for the treatment of uveal melanoma: A case series
by: Yanina Jeanne Leona Jansen, et al.
Published: (2020-11-01)

Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas
by: Kai Wang, et al.
Published: (2023-07-01)

Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma
by: Piotr J. Błoński, et al.
Published: (2024-03-01)

Adjuvant and neoadjuvant therapies in melanoma
by: Teresa Amaral, et al.
Published: (2020-10-01)

Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States
by: Wentao Tian, et al.
Published: (2023-09-01)

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
by: Christopher A. Lemmon, MD, et al.
Published: (2022-07-01)

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
by: Ramses Sadek, et al.
Published: (2021-06-01)

Real-world experience with pembrolizumab toxicities in advanced melanoma patients: a single-center experience in the UK
by: Alfred CP So, et al.
Published: (2018-03-01)

Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
by: Sasson, SC, et al.
Published: (2021)

Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma
by: Anna L. Cogen, MD, PhD, et al.
Published: (2018-03-01)

Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
by: S. C. Sasson, et al.
Published: (2021-09-01)

Neoadjuvant pembrolizumab-carboplatin-paclitaxel in locally advanced squamous cell carcinoma of the oral cavity: A case report and literature review
by: Abdulrahman Hesham, et al.
Published: (2024-09-01)

Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial
by: Isabelle L. Ray-Coquard, et al.
Published: (2024-07-01)

Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
by: Yulong Chen, et al.
Published: (2023-09-01)

Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.
by: Petrella, T, et al.
Published: (2017)

Prior Therapy With Pegylated-Interferon Alfa-2b Improves the Efficacy of Adjuvant Pembrolizumab in Resectable Advanced Melanoma
by: Dong-Dong Jia, et al.
Published: (2021-06-01)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
by: Diogo Garcia, et al.
Published: (2021-06-01)

Comparative Analysis of Pembrolizumab Dosing Schedules in the Adjuvant Treatment of Malignant Melanoma
by: Y. Ahmed, et al.
Published: (2024-01-01)

Case report: Low-dose radiation reverses pembrolizumab resistance in melanoma
by: Ka Hey Agnes Fong, et al.
Published: (2025-02-01)

Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
by: Sanju Cyriac, et al.
Published: (2022-01-01)

243 Real world exposure survival relationship of pembrolizumab in metastatic melanoma
by: Vishal Navani, et al.
Published: (2020-11-01)